Trypsin from genetically modified plants
(April 15, 2002 – CropChoice news) – ProdiGene, Inc. announced that it will soon be extracting a key pharmaceutical component from
genetically modified plants.
Trypsin, is a protein used in cell culture and to produce pharmaceuticals, particularly insulin; it usually comes from bovine sources.
ProdiGene plans to market this plant-based trypsin by the end of 2002 and achieve full-scale production shortly thereafter.
The company received a grant from the National Institutes of Health to genetically modify corn to deliver an edible AIDS vaccine.
Source: Cropbiotech Net